Search Immortality Topics:

Page 21234..1020..»

Category Archives: Pharmacogenomics

Updated Scientific Program | Euro Personalized Medicine …

Sessions and Tracks The 6thEuropeanConference on Predictive Preventive and Personalized Medicine & Molecular Diagnostics will be held on September 14-15, 2017 at Edinburgh, Scotland will be organized around the themeUnleashing the novel approaches in advancing Personalized Medicinewhichcomprises 23 Sessions/Tracksto outline the theme of the conference organized by conferenceseries LLCConferences. The main aim of the conference is to highlight the achievements and innovations in the various fields of Personalized Medicine across the globe. Track 1: Molecular Diagnostics in Personalized Medicine In personalized medicine molecular diagnostics is used for analysing of biological markers and also analysing by applying molecular biology to medical testing .This technique is used to diagnose and monitor disease,detect risk in individual patients .DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule .SNP genotyping is the measurement of genetic variations of single nucleotide polymorphism (SNPs) . Continue reading

Posted in Pharmacogenomics | Comments Off on Updated Scientific Program | Euro Personalized Medicine …

Global Biomarkers Technologies, Markets and Companies Projections Report 2017 – PR Newswire (press release)

This report describes different types of biomarkers and their discovery using various -omics technologies such as proteomics and metabolomics. Molecular diagnostics technologies are used for the discovery of biomarkers and new tests are also based on biomarker. This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Continue reading

Posted in Pharmacogenomics | Comments Off on Global Biomarkers Technologies, Markets and Companies Projections Report 2017 – PR Newswire (press release)

10th International Conference on Genomics and Pharmacogenomics – Technology Networks

Theme: Advanced Approaches in Genomics and Pharmacogenomics It gives us immense pleasure to announce the conference that is 10th International Conference on Genomics & Pharmacogenomics. Genomics 2018 will provide a perfect platform to all the Scientists, Researchers, Students and Business Delegates to approach and deliver all the attendees about the latest scientific advancements on the respective sphere Continue reading

Posted in Pharmacogenomics | Comments Off on 10th International Conference on Genomics and Pharmacogenomics – Technology Networks

PGxOne Pharmacogenomics Test | Admera Health

ACE Inhibitors Benazepril (Lotensin) ACE Captopril (Capoten) ACE AGTR1 Perindopril (Aceon) ACE AGTR1 Quinapril (Accupril) ACE Angiotensin II Receptor Blockers Candesartan (Atacand) AGTR1 Irbesartan (Avapro) ACE Losartan (Cozaar) ABCB1 AGTR1 Antianginal Agent Ranolazine (Ranexa) CYP2D6 Antiarrhythmic Agent Amiodarone (Cordarone) CYP3A4 NOS1AP Digoxin (Lanoxin) ABCB1 Dronedarone (Multaq) CYP3A4 Flecainide (Tambocor) CYP2D6 Propafenone (Rythmol) CYP2D6 Anticoagulants Phenprocoumon (Marcoumar) CYP4F2 Rivaroxaban (Xarelto) CYP3A4 Warfarin (Coumadin) CYP2C9 VKORC1 Antiplatelets Clopidogrel (Plavix) CYP2C19 Ticagrelor (Brilinta) CYP3A4 Beta Blockers Atenolol (Tenormin) ADRA2A Carvedilol (Coreg) CYP2D6 Nebivolol (Bystolic) CYP2D6 Propranolol (Inderal LA) CYP2D6 Metoprolol Tartrate (Lopressor) CYP2D6 Calcium Channel Blockers Amiodarone (Cordarone) NOS1AP Amlodipine (Norvasc) CYP3A4 NOS1AP Diltiazem (Cardizem) CYP3A4 Felodipine (Plendil) CYP3A4 Lercanidipine (Zanidip) CYP3A4 Nifedipine (Adalat) NOS1AP Nisoldipine (Sular) CYP3A4 Nitrendipine (Nitrepin) AGTR1 CYP3A4 Verapamil (Calan) NOS1AP Diuretics Bumetanide (Bumex) ACE Furosemide (Lasix) ACE Hydrochlorothiazide (Microzide) ACE AGTR1 Spironolactone/HCTZ (Aldactazide) ADTR1 ACE Spironolactone (Aldactone) ACE Torasemide (Demadex) ACE Phosphodiesterase Inhibitors Cilostazol (Pletal) CYP3A4 Antilipemic Agent Atorvastatin (Lipitor) ABCB1 APOE CYP3A4 CYP3A5 KIF6 SLCO1B1 Fluvastatin (Lescol) ACE Lovastatin (Mevacor) CYP3A4 CYP3A5 Pitavastatin (Livalo) SLCO1B1 Pravastatin (Pravachol) KIF6 SLCO1B1 Rosuvastatin (Crestor) SLCO1B1 Simvastatin (Zocor) ABCB1 CYP3A4 CYP3A5 SLCO1B1 Atorvastatin/Ezetimibe (Liptruzet) ABCB1 APOE CYP3A4 KIF6 SLOC1B1 Fenofibrate (Tricor) APOE Simvastatin/Ezetimibe (Vytorin) ABCB1 SLCO1B1 Vasodilators Nitroprusside (Nipride) ACE Hydralazine NAT2 Hydralazine/Isosorbide (Bidil) NAT2 Miscellaneous Cardiovascular Agents Ivabradine (Corlanor) CYP3A4 ACE Inhibitors/Diuretics Quinapril/HCTZ (Accuretic) ACE AGTR1 Captopril/HCTZ (Capozide) ACE AGTR1 Benazepril/HCTZ (Lotensin HCT) ACE AGTR1 Lisinopril/HCTZ (Prinzide) AGTR1 Enalapril/HCTZ (Vaseretic) AGTR1 ARBs/Diuretics Candesartan/HCTZ (Atacand HCT) AGTR1 Irbesartan/HCTZ (Avalide) ACE AGTR1 Losartan/HCTZ (Hyzaar) AGTR1 ABCB1 Beta-Blocker/Diuretic Metoprolol/HCTZ (Lopressor HCT) CYP2D6 AGTR1 CCB/ACE Inhibitor Amlodipine/Benazepril (Lotrel) ACE CYP3A4 NO1SAP Continue reading

Posted in Pharmacogenomics | Comments Off on PGxOne Pharmacogenomics Test | Admera Health

Pharmacogenomics Market: Improving Healthcare Infrastructure in APAC Incrementing Demand – Edition Truth

Therapeutic applications such as cardiology, oncology, neurological disorder, and pain management will keep the global Pharmacogenomics Market in good stead in the near future. Continue reading

Posted in Pharmacogenomics | Comments Off on Pharmacogenomics Market: Improving Healthcare Infrastructure in APAC Incrementing Demand – Edition Truth

PHG Foundation – Interactive Tutorial: Pharmacogenomics …

Pharmacogenetics refers to the study of genetic influences on an individuals response to drugs. In pharmacogenetics, the analysis of a specific gene, or group of genes, may be used to predict responses to a specific drug or class of drugs. Pharmacogenomics refers collectively to all the genes that influence drug responses, and how genome-wide analysis may be used to identify such genes in the search for novel drug targets and/or key determinants of drug reactions Continue reading

Posted in Pharmacogenomics | Comments Off on PHG Foundation – Interactive Tutorial: Pharmacogenomics …